Does Cannabis Modify Cortisol or Stress Hormone Levels? 

Cannabis, particularly its active compounds tetrahydrocannabinol (THC) and cannabidiol (CBD), has long been studied for its impact on mood, stress, and anxiety. However, a lesser-known effect involves the body’s stress response system, particularly the hypothalamic–pituitary–adrenal (HPA) axis, which regulates the production of cortisol, the primary stress hormone. This article explores current evidence (2020–2025) on how cannabis influences cortisol and other stress hormones. 

Understanding Cortisol and the HPA Axis 

Cortisol helps regulate metabolism, immune responses, and the body’s reaction to stress. The HPA axis governs this process, linking the brain and adrenal glands in a finely tuned hormonal feedback system. Cannabis compounds interact with the body’s endocannabinoid system, which also influences stress regulation. Research shows that both THC and CBD can affect cortisol levels, but the outcomes vary depending on factors like dosage, frequency, and individual tolerance. 

Acute Effects of Cannabis on Cortisol 

THC 

THC tends to increase cortisol levels in the short term. Several studies have shown that acute THC exposure, such as smoking or vaporisation, activates the HPA axis and elevates cortisol within 15–60 minutes of consumption. For example, a 2021 Frontiers in Psychology study found that THC use triggered a stress-like cortisol response. Similarly, a 2024 Progress in Neuro-Psychopharmacology & Biological Psychiatry study confirmed short-term increase in cortisol levels following THC exposure.  

However, individual responses differ. Tolerance, dose, and prior cannabis exposure influence how much cortisol rises, and at higher doses, THC may induce anxiety-like effects linked to this hormonal surge. 

CBD 

CBD appears to reduce or blunt cortisol release, especially under stress. In one 2023 Psychoneuroendocrinology study, CBD reduced cortisol output following a stress-inducing task. Interestingly, even the expectation of CBD intake without active ingredients produced similar effects, suggesting a psychobiological influence as well (2024 placebo-controlled study, Frontiers in Pharmacology). 

Mechanistically, CBD’s calming effect is linked to 5-HT1A receptor activation and modulation of glucocorticoid signalling, as described in a 2024 preclinical analysis and 2023 review in Frontiers in Pharmacology. 

Chronic Use and Cortisol Regulation 

Chronic cannabis users often show altered baseline cortisol levels. Multiple studies indicate that while long-term users may have higher resting cortisol, they display a blunted HPA axis response to stress or THC exposure. A 2024 PubMed review reported flattened daily cortisol rhythm among heavy cannabis users, including reduced morning cortisol peaks and weaker cortisol awakening responses. Early-onset users appear especially affected, as first shown in a 2006 longitudinal study. These adaptations suggest HPA axis desensitisation caused by repeated CB1 receptor activation essentially; the stress system becomes less responsive over time. 

Mechanisms Behind Cannabis’ Effect on the HPA Axis 

THC And HPA Activation 

THC binds to CB1 receptors in regions such as the amygdala, hypothalamus, and hippocampus, acutely stimulating the HPA axis. This leads to cortisol release, mimicking a stress response. Chronic exposure, however, appears to downregulate receptor activity, producing a weaker cortisol reaction to later stress. A 2021 Journal of Neuroendocrinology review supports this pattern of short-term activation followed by long-term desensitisation. 

CBD And Stress Regulation 

In contrast, CBD interacts indirectly with both the endocannabinoid and serotonin systems, promoting stress balance. Evidence suggests CBD normalises HPA function disrupted by chronic stress or THC exposure, helping restore typical cortisol regulation (Frontiers in Pharmacology, 2023). 

Prenatal And Developmental Findings 

Evidence from developmental studies indicates maternal cannabis use during pregnancy may influence cortisol regulation in children. A 2021 cohort study published on PubMed found elevated hair cortisol levels in six-year-olds exposed to cannabis in utero, suggesting long-term programming effects on the HPA axis. Paternal cannabis use, however, showed no such correlation. 

Health Authority Guidance 

According to NICE guidance NG144, cannabis-based medicinal products are currently licensed only for specific conditions such as chronic pain, chemotherapy-induced nausea, and certain epilepsy forms. There are no recommendations for the use of cannabis or CBD to regulate cortisol or stress. 

The NHS and WHO similarly emphasise that evidence remains limited. They caution that while public interest in CBD for anxiety or stress relief is high, clinical data are still insufficient, and product quality varies widely. 

Clinical Bottom Line 

• Acute THC use increases cortisol via HPA axis activation, mimicking a stress response (Frontiers in Psychology, 2021). 

• Chronic cannabis use results in higher baseline cortisol but a blunted stress response, consistent with HPA desensitisation (PubMed, 2024). 

• CBD reduces or blunts cortisol reactivity, possibly through 5-HT1A and endocannabinoid modulation (Frontiers in Pharmacology, 2023). 

• Prenatal exposure to cannabis may cause long-term elevation of child cortisol levels (PubMed, 2021). 

• Health authorities, including the NHS and NICE, do not recommend cannabis for managing cortisol or stress. 

Educational Context: AlleviMed 

AlleviMed provides public education on medical cannabis regulation and eligibility in the UK. The platform explains how cannabis-based medicinal products are prescribed under MHRA and Home Office frameworks. It does not promote cannabis use for stress but helps individuals understand evidence-based access pathways for licensed indications such as epilepsy and pain. 

Takeaway 

Cannabis interacts intricately with the body’s stress system. THC tends to raise cortisol acutely, reflecting a stress-like physiological response, whereas CBD often lowers cortisol and moderates anxiety-related reactivity. Over time, chronic cannabis use may blunt the body’s ability to respond to stress by desensitising the HPA axis. 

Despite growing public interest, medical authorities like NICE, the NHS, and WHO do not currently recommend cannabis for managing stress or cortisol imbalance due to inconsistent evidence and safety considerations.